The 20 Best X-Linked Retinal Dysplasia Doctors Near Me in New York, NY
Find the Top X-Linked Retinal Dysplasia Experts and Specialists
The 20 Best X-Linked Retinal Dysplasia Doctors near New York, NY
MediFind found 115 doctor with experience in X-Linked Retinal Dysplasia near New York, NY. Of these, 98 are Experienced and 17 are Advanced.
Susan Fromer is an Ophthalmologist in New York, New York. Dr. Fromer is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. Her top areas of expertise are Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis.
Northwell Health Physician Partners At Greenwich Village, 3rd Floor
Amilia Schrier is an Ophthalmologist in New York, New York. Dr. Schrier is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. Her top areas of expertise are Cataract, Blepharitis, Meibomianitis, Cataract Removal, and Vitrectomy.
Northwell Health Physician Partners Ophthalmology At MEETH
Naomi Goldberg is an Ophthalmologist in New York, New York. Dr. Goldberg is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, and Neuroretinitis.
Northwell Health Physician Partners Ophthalmology At MEETH
Talia Kaden is a General Surgeon and an Ophthalmologist in New York, New York. Dr. Kaden is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. Her top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.
Northwell Health Physician Partners Ophthalmology At MEETH
Isha Cheela is an Ophthalmologist in New York, New York. Dr. Cheela is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. Her top areas of expertise are Cataract, Keratoconus, Dry Eye Syndrome, Meibomianitis, and Corneal Transplant.
Northwell Health Physician Partners Ophthalmology At MEETH
"William M. Schiff, MD is a board certified Ophthalmologist, specializing in the medical and surgical management of vitreous and retinal diseases. He is the Director of Ophthalmic Surgery at Manhattan Eye Ear and Throat Hospital (MEETH) and serves an educational role as the Co-Director of the Vitreoretinal Fellowship Program. Dr. Schiff's practice encompasses the management of medical and surgical diseases of the vitreous, retina, and macula including macular degeneration, macular hole, epiretinal membrane, diabetic retinopathy and retinal detachment. Dr. Schiff was previously Professor of Clinical Ophthalmology at Columbia University, College of Physicians and Surgeons. He has lectured widely, has authored or coauthored more than 50 publications, and is an active member of numerous professional societies and organizations including The American Academy of Ophthalmology, The Retina Society, The American Society of Retinal Specialists and the New York Ophthalmologic Society. Dr. Schiff has earned the Achievement Award from the American Academy of Ophthalmology and the Honor's Award from the American Society of Retina Specialists. He has been named in ""New York Magazine's Best Doctors,"" Castle Connolly's ""America's Top Doctors"" and Castle Connolly's ""Top Doctors in the New York Metro Area.""". Dr. Schiff is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Vitrectomy, and Cataract Removal.
Angioletti Retina Associates
Louis Angioletti is an Ophthalmologist in New York, New York. Dr. Angioletti is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Retinal Vein Occlusion.
Brian N. Campolattaro
Brian Campolattaro is an Ophthalmologist in New York, New York. Dr. Campolattaro is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Strabismus, Esotropia, Brown Syndrome, and Coloboma of Optic Papilla.
K. Bailey Freund, MD specializes in diagnosis, treatment and care of patients with all retinal disorders including macular degeneration, diabetic retinopathy, and retinal vascular and inflammatory diseases and is an expert in difficult-to-diagnose and rare conditions. He has been at the forefront of pivotal national clinical trials as a principal investigator for treatments for retinal diseases, providing his patients access to the latest solutions and remedies utilizing the most state of the art diagnostic equipment.Dr. Freund is internationally recognized in his field and is a member of the Retina Society, Macula Society, and the American Society of Retina Specialists. He is on the Editorial Board of the journal Retina and is an Associate Editor for Retinal Cases & Brief Reports. He has authored over 250 peer-reviewed scientific manuscripts and has written numerous book chapters. He has received numerous awards including the prestigious Young Investigator Award from the Macula Society.He is a graduate of Williams College and the New York University School of Medicine and completed his residency training in general ophthalmology and fellowship in medical and surgical retina at the Manhattan Eye, Ear, and Throat Hospital. Dr. Freund was born and raised in Manhattan and continues to reside here with his wife and his two children. Dr. Freund enjoys playing the guitar and is a prominent collector of vintage magic apparatus. Dr. Freund is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Choroid Plexus Carcinoma.
Sophia Siu is an Ophthalmologist in Brooklyn, New York. Dr. Siu is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. Her top areas of expertise are Neuroretinitis, Kallikrein Hypertension, Glaucoma, and Dry Eye Syndrome.
Ronald Concetto Gentile MD PC
Deep Parikh is an Ophthalmologist in New York, New York. Dr. Parikh is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Neuroretinitis, Uveitis, Endophthalmitis, and Scleritis.
Downtown Eyecare - Eric Dessner MD
Eric Dessner is an Optometry provider in Brooklyn, New York. Dr. Dessner is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Dry Eye Syndrome, Blepharitis, Strabismus, and Presbyopia.
Office
Frederick Wang is a Pediatrics provider in New York, New York. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Epicanthal Folds, Strabismus, Esotropia, and X-Linked Retinal Dysplasia.
Office
Kevin Myers is an Ophthalmologist in Brooklyn, New York. Dr. Myers is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Retinal Vasculopathy with Cerebral Leukodystrophy, Coats Disease, Familial Exudative Vitreoretinopathy, and Dry Eye Syndrome.
ColumbiaDoctors - Third Avenue
Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.
Vitreous Retina Macula Consultants Of New York
Michael Engelbert is an Ophthalmologist in New York, New York. Dr. Engelbert is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.
Vitreous Retina Macula Consultants Of New York
James Klancnik is an Ophthalmologist in New York, New York. Dr. Klancnik is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.
Rochelle L Peck MD PC
Gregory Stein is an Ophthalmologist in New York, New York. Dr. Stein is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Diabetic Retinopathy, Kallikrein Hypertension, Dry Eye Syndrome, Late-Onset Retinal Degeneration, and Vitrectomy.
KKB Medical P.C.
Michael Nissen is an Ophthalmologist in New York, New York. Dr. Nissen is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Choroid Plexus Carcinoma, Neuroretinitis, and Vitrectomy.
Metro Eye MD
Nicholas Nissirios is an Ophthalmologist in Astoria, New York. Dr. Nissirios is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinal Dysplasia. His top areas of expertise are Dry Eye Syndrome, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Eyelid Bump.
Last Updated: 02/22/2026








